FGFR1 abrogates inhibitory effect of androgen receptor concurrent with induction of androgen-receptor variants in androgen receptor-negative prostate tumor epithelial cells-Reference-Cited by-同舟云学术

FGFR1 abrogates inhibitory effect of androgen receptor concurrent with induction of androgen-receptor variants in androgen receptor-negative prostate tumor epithelial cells

Published:2011-03-28 Issue:15 Volume:71 Page:1691-1700
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Kobayashi Masashi,Huang Yanqing,Jin Chengliu,Luo Yongde,Okamoto Tetsuji,Wang Fen,McKeehan Wallace L.

Publisher

Wiley

Subject

Urology,Oncology

Reference47 articles.

1. Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis;Scher;J Clin Oncol,2005

2. Molecular genetics of prostate cancer: New prospects for old challenges;Shen;Genes Dev,2010

3. Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails;Niu;Oncogene,2010

4. Prolonged control of progressive castration-resistant metastatic prostate cancer with testosterone replacement therapy: The case for a prospective trial;Mathew;Ann Oncol,2008

5. Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer;Morris;Eur Urol,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer;European Urology Oncology;2021-11

2. Fibroblast Growth Factor Family in the Progression of Prostate Cancer;Journal of Clinical Medicine;2019-02-04

3. Androgen receptor (AR) expression in prostate cancer and progression of the tumor: Lessons from cell lines, animal models and human specimens;Steroids;2012-08